🔴 Clearpoint Neuro is trading 9.6% down in pre-market

Clearpoint Neuro is trading 9.6% down at $8.20 in pre-market, with no company-specific announcement identified to explain the decline.

• The latest company announcement schedules third-quarter results for October 28, after market close.
• The supplied market snapshot is mixed, with the Nasdaq higher, so it does not clearly explain the decline.
• The October 16 sell-off and earlier sector concerns are background, not confirmed catalysts for this pre-market move.